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Abstract
Background: Cell-mediated immunity is critical for clearance of central nervous system (CNS) infection with the
encephalitic flavivirus, West Nile virus (WNV). Prior studies from our laboratory have shown that WNV-infected
neurons express chemoattractants that mediate recruitment of antiviral leukocytes into the CNS. Although the
chemokine receptor, CCR5, has been shown to play an important role in CNS host defense during WNV infection,
regional effects of its activity within the infected brain have not been defined.
Methods: We used CCR5-deficient mice and an established murine model of WNV encephalitis to determine
whether CCR5 activity impacts on WNV levels within the CNS in a region-specific fashion. Statistical comparisons
between groups were made with one- or two-way analysis of variance; Bonferroni’s post hoc test was subsequently
used to compare individual means. Survival was analyzed by the log-rank test. Analyses were conducted using Prism
software (GraphPad Prism). All data were expressed as means ± SEM. Differences were considered significant if P≤ 0.05.
Results: As previously shown, lack of CCR5 activity led to increased symptomatic disease and mortality in mice
after subcutaneous infection with WNV. Evaluation of viral burden in the footpad, draining lymph nodes, spleen,
olfactory bulb, and cerebellum derived from WNV-infected wild-type, and CCR5−/− mice showed no differences
between the genotypes. In contrast, WNV-infected, CCR5−/− mice exhibited significantly increased viral burden in
cortical tissues, including the hippocampus, at day 8 post-infection. CNS regional studies of chemokine expression via
luminex analysis revealed significantly increased expression of CCR5 ligands, CCL4 and CCL5, within the cortices of
WNV-infected, CCR5−/− mice compared with those of similarly infected WT animals. Cortical elevations in viral
loads and CCR5 ligands in WNV-infected, CCR5−/− mice, however, were associated with decreased numbers of
infiltrating mononuclear cells and increased permeability of the blood-brain barrier.
Conclusions: These data indicate that regional differences in chemokine expression occur in response to WNV
infection of the CNS, and that cortical neurons require CCR5 activity to limit viral burden in this brain region.
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Background
Infection with the encephalitic flavivirus, West Nile virus
(WNV), is the leading cause of domestically acquired
arboviral disease in the USA [1]. Acute infectious syn-
dromes after infection with WNV include a self-limited
febrile illness, West Nile fever (WNF), or more severe
neuroinvasive diseases (WNND), including meningitis, en-
cephalitis, or flaccid paralysis. The entry of virus-specific
T cells into the CNS parenchyma is essential for viral
clearance and survival in both human and murine subjects
with WNV encephalitis [2–6]. Indeed, the increased in-
cidence of WNV neuroinvasive disease in patients on
anti-T cell therapies [5, 7] and in mice with T cell defi-
ciencies [4, 8–10] indicates that the clearance of WNV
within the CNS relies heavily on cell-mediated immune
responses that promote the CNS entry and effector func-
tions of CD8+ T cells [11, 12]. While studies indicate that
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CNS regions differ in the extent of inflammatory infiltrates
during viral encephalitis [13–16], regional differences in
expression of guidance cues that promote T cell entry have
not been established. These guidance cues, combined with
the tightly controlled egress of leukocytes from the peri-
vascular sites, coordinate the migration of leukocyte sub-
sets for protective and pathologic purposes.
In most tissues, leukocyte recruitment is orchestrated by
a series of coordinated leukocyte-endothelial interactions
involving several families of molecular regulators including
selectins, integrins, and chemokines [17, 18]. Chemokines
are a superfamily of over 50 structurally homologous
chemotactic, heparin binding, secreted proteins with their
target cell specificity conferred by pertussis toxin (PTX)
sensitive, Gαi-coupled seven transmembrane glycopro-
tein chemokine receptors. Of interest, CXCL12 and its
receptors are believed to most resemble the ancestral
chemokine-receptor pair [19] suggesting that CXC che-
mokines are evolutionarily older than CC chemokines. In
published studies, we have determined that upregulation
of proinflammatory chemokines during WNV encephalitis
may occur in a region-specific fashion [2, 20]. For ex-
ample, cerebellar expression of CXCL10 is required for
viral clearance of this brain region by CXCR3-expressing,
virus-specific CD8+ T cells [20]. Differences in regional
chemokine expression may thus determine the spatial pat-
terns of leukocyte trafficking, leading to variability in viral
clearance and immunopathology between CNS regions.
CCL3–5, chemokines that all bind the chemokine re-
ceptor CCR5, are strongly induced in the CNS after WNV
infection [2, 21–23]. Monocytes, NK and T cells express
CCR5 and targeted deletion of CCR5 in B6129PF2 mice is
associated with depressed leukocyte trafficking, increased
viral burden and enhanced mortality [21]. Similarly,
homozygosity for CCR5Δ32, a nonfunctional variant of
chemokine receptor CCR5, is markedly increased among
symptomatic WNV-seropositive patients [22, 24]. In
the current study, we examined the role of CCR5 in
C57BL/6 mice during WNV infection, focusing on CNS
region-specific effects. We found that CCR5 is required
for virologic control specifically within the CNS cortex.
This finding was associated with a significant decrease in
immune cell infiltrates, increased blood-brain barrier (BBB)
permeability, and elevated levels of CCR5 ligands in WNV-
infected CCR5−/− compared with WT mice. These data
suggest that increased viral replication within the CNS
modulates BBB function and support the notion that non-
redundancy in chemokine-mediated inflammation among
CNS regions may be due to evolutionary mechanisms.
Methods
Murine model of WNV encephalitis
Eight-week-old C57BL/6 wild-type mice were obtained
commercially (Jackson Laboratories). Congenic ccr5−/−
mice were also commercially obtained (Jackson Labora-
tories, stock number 005427) and bred in the animal facil-
ities at the Washington University School of Medicine. All
animals were housed under pathogen-free conditions in
the animal facilities of the Washington University School
of Medicine. All experiments were performed in compli-
ance with Washington University animal studies guide-
lines and comply with “Animal Research: Reporting In
Vivo Experiments (ARRIVE) guidelines.” Mice were in-
oculated subcutaneously via footpad injection (50 μl)
with 100 PFU of WNV as previously described [25].
WNV strain 3000.0259 was isolated in New York in
2000 [26] and passaged once in C6/36 cells. Viral titers
were measured by plaque assay on BHK21-15 cells as
previously described [27]. Cortical, cerebellar, and brain-
stem regions of the CNS were dissected based on visual
information, such as differences in color of adjacent tis-
sues, and on the natural anatomical boundaries of cer-
tain regions present in the brain. Clinical disease was
monitored and scored as previously described [28]. The
designation for the clinical scores is as follows: 1 ruffled
fur/hunched, 2 paresis/difficulty walking, 3 paralysis, 4
moribund, and 5 dead.
BBB permeability assay
At day 5 and 8 after WNV infection, mice were injected
intraperitoneally (IP) with sodium fluorescein dye
(100 mg/ml) as previously described [29]. After 45 min,
mice were perfused, serum was collected, and CNS tissues
were harvested. Both the serum and tissue homogenates
were incubated overnight at 4 °C in 2 % trichloroacetic
acid at 1:1 dilution to precipitate protein and then the su-
pernatants were neutralized in equal volumes of borate
buffer. Fluorescence emission at 538 nm was determined
using a microplate reader Synergy™ H1 and Gen5™ soft-
ware (BioTek Instruments, Inc.). Fluorescence concentra-
tion was calculated from a standard curve, and tissue
fluorescence values were normalized to serum fluores-
cence values from identical mice.
Chemokine analysis
The chemokine Bio-Plex assay was performed on tissue
samples from mice at day 8 after infection from WNV-
infected mice. Tissue was homogenized following ex-
tensive cardiac perfusion with PBS and was analyzed
using a 6-plex Luminex assay (Millipore) followed by
analysis on a Bio-Plex 200 (Bio-Rad). Concentrations of
chemokines were normalized to total protein levels.
Leukocyte isolation
Cells were isolated from the CNS of WT and CCR5−/−
mice at day 6 and 8 after WNV infection. Following cell
count and viability analysis, cells were stained with fluo-
rescently conjugated antibodies to CD4, CD8β, CD11b,
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and CD45 as previously described [30]. Samples were
analyzed following staining using a LSRII flow cytometer
(Beckton Dickinson) to collect up to 30,000 events in a
broad gate defined by forward- and side-scatter attri-
butes. The absolute count of respective leukocyte sub-
sets was calculated based on the percent positive cells
from data analysis, which was performed using FlowJo
software (Tree Star).
Immunohistochemistry
Brain tissues were perfused with 4 % paraformaldehyde
and isolated for frozen sections. Tissue sections were
permeabilized and blocked in 0.1 % Triton X-100 and
10 % goat serum, followed by incubation with primary
antibodies CD-3 1:200 (Dako) and WNV antigen 1:100
(Diamond lab) or CD-3 1:200 (Dako), CD31 1:20 (BD)
and endomucin 1:200 (eBioscience/Affymetrix) over-
night at 4 °C. Primary antibodies were detected with
goat anti-rabbit Alexa Fluor 488 (CD3), goat anti-rat
Alexa Fluor 555 (WNV antigen) and goat anti-rat Alexa
Fluor 555 (CD31, endomucin) followed by nuclear DAPI
counterstaining. Tissues were then washed and exam-
ined by confocal microscopy.
Statistical analysis
Statistical comparisons between groups were made with
one- or two-way analysis of variance; Bonferroni’s post
hoc test was subsequently used to compare individual
means. Survival was analyzed by the log-rank test. Ana-
lyses were conducted using Prism software (GraphPad
Prism). All data were expressed as means ± SEM. Dif-
ferences were considered significant if P ≤ 0.05.
Results
CCR5-deficient mice exhibit higher cortical viral loads
with increased BBB permeability
In prior studies, mice with targeted deletion of CCR5
(B6129PF2 background) exhibited 100 % lethality after sub-
cutaneous inoculation with WNV-NY (strain NY9935262;
104 ffu), which was attributed to the decreased CNS entry
of all leukocyte subpopulations including macrophages,
T and NK cells [21]. In this study, mortality due to
WNV infection was not significantly enhanced by in-
creases in WNV inoculum beyond 102 focus-forming
units. To determine whether CCR5-deficient animals
(C57BL/6 background) exhibited similar survival effects,
8-week-old, C57BL/6 wild-type (WT), and CCR5-deficient
mice were infected subcutaneously via footpad inoculation
with 102 plaque-forming units (PFU) of strain WNV-
NY99 and followed for severity of disease and survival.
WNV-infected CCR5−/− mice exhibited enhanced mortal-
ity (Fig. 1a, WT 20 %; CCR5−/− 50 %) and significantly
higher clinical disease severity scores (Fig. 1b, c), com-
pared with similarly infected WTanimals. Analysis of viral
loads in the footpad and peripheral organs did not re-
veal differences between the two genotypes at any time
points after WNV infection (Fig. 2a). In contrast, ana-
lyses of CNS tissues detected significantly higher viral
loads in the cortices, but not within the brainstem or
cerebella, of WNV-infected CCR5−/− compared with
WT mice (Fig. 2b). Of note, because of the difference
in survival observed between genotypes, the CCR5-
deficient mice assessed at day 10 do not include those
that have succumbed to viral encephalitis and will natur-
ally include those with lower viral titers that do survive.
WT animals exhibit more survival and generally exhibit
peak viral loads at days 8–10, which undergo clearance
thereafter [3, 12], leading to similar viral loads at this later
time point. These data suggest that CCR5 is critical for vi-
rologic control specifically within the cortex during WNV
encephalitis.
In recently published studies, we demonstrated that
detection of WNV by host tissues induces local innate
immune cytokine expression by CNS endothelium,
regulating BBB structure and function [29]. Given the
increased viral load in the cortices of CCR5−/− mice
compared with similarly infected WT, we performed
fluorometric assessment of BBB permeability following
the intraperitoneal (IP) administration of sodium fluor-
escein. Cerebellar and brainstem tissues derived from
WNV-infected WT and CCR5−/− mice exhibited similar
increases in extravasation of sodium fluorescein at 5
and 8 days post-infection (Fig. 3). However, similar ana-
lyses of cortical tissues revealed a significant increase in
BBB permeability at 8 days post-infection in CCR5−/−
mice compared with WT controls (Fig. 3). These find-
ings are consistent with previous data linking higher
viral loads with worsened BBB stability [31, 32].
CCR5-deficient mice exhibit increased chemokines within
the cortex with less inflammation
In prior studies, elevated viral loads within the CNS of
WNV-infected mice were also linked to increased ex-
pression of chemoattractant cytokines [2, 33]. Consistent
with this, at time points when viral loads in the cortices
of WNV-infected CCR5−/− mice are highest, levels of
CCR5 ligands, CCL3 and CCL5, were significantly ele-
vated compared with cortical tissues of similarly infected
WT mice (Fig. 4a). Moreover, there were no differences
between the genotypes in chemokine expression levels
in the cerebella of WNV-infected mice (Fig. 4b). Given
the increase in CCR5 chemoattractants and increased
BBB permeability, we wondered whether WNV-infected
CCR5 mice would exhibit increased parenchymal entry
of mononuclear cells. To address this, we performed
flow cytometric analyses of infiltrating mononuclear cells
within the cortices and cerebella of WNV-infected WT
versus CCR5−/− mice on days 5, 8, and 10 post-infection.
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Inflammatory infiltrates, CD45hi leukocytes, within the
cerebella of WNV-infected WT and CCR5-deficient
mice peaked at day 8 post-infection and exhibited simi-
lar total numbers of CD45lo and CD45hi mononuclear
cells (Fig. 5a). In contrast, total numbers of infiltrating
CD45hi leukocytes were significantly higher in cortical
tissues of WNV-infected WT mice, compared with their
CCR5−/− counterparts, on day 8 post-infection (Fig. 5c).
Although similar numbers of CD45hi infiltrating leuko-
cytes, comprised of CD4+ and CD8+ (lymphocytes) and
CD11b+ (macrophages) were present between WT and
CCR5−/− mice in the cerebellar tissues on day 8 following
WNV infection (Fig. 5b), the total number of CD45hi CD4
+ and CD8+ lymphocytes was significantly decreased in the
cortices of CCR5-deficient, WNV-infected mice on day 8
post-infection (Fig. 5d). CD45hi CD11b+ leukocytes (mac-
rophages) were decreased in both genotypes on 10 post-
infection (Fig. 5d). Immunohistochemical analyses of T cell
infiltration within the cortices of WNV-infected, WT and
CCR5−/− mice at day 8 post-infection revealed T cell infil-
tration with little WNV antigen in WT hosts. In contrast,
low numbers of parenchymal T cells were detected within
Fig. 1 CCR5 is necessary to reduce WNV-associated disease and mortality. WT and CCR5−/− mice were infected with 102 PFU of WNV via the
subcutaneous route. a Survival was monitored for 28 days after infection. n = 30 mice, *P = 0.0503 (log-rank test). b Clinical scores were monitored daily
for 12 days after infection. The designation for the clinical scores is as follows: 1 ruffled fur/hunched; 2 altered gait, slow movement; 3 not moving but
responsive; 4 moribund; and 5 death. c Individual clinical scores are shown at each time point for WT (left) and CCR5−/− (right) mice. Asterisks indicate
values that are statistically significant (**P < 0.005, ***P < 0.001)
Fig. 2 CCR5 restricts WNV replication in cortical tissues of the CNS. WT and CCR5−/− mice were infected via footpad with 102 PFU of WNV.
a Viral burden within the footpad, draining lymph node (popliteal LN), and spleen of WT and CCR5−/− mice were measured at indicated days
post-infection. b WNV levels within the cortex, cerebellum, and brainstem were measured at days 6, 8, and 10 post-infection. Tissue homogenates were
analyzed for viral burden by infectious plaque assay. Data are shown as the mean PFU per gram of tissue from 6 to 10 mice per time point. Dotted lines
denote the limit of detection of the respective assays. Asterisks indicate values that are statistically significant (*P < 0.05)
Durrant et al. Journal of Neuroinflammation  (2015) 12:233 Page 4 of 8
CCR5-deficient hosts, despite increased detection of WNV
antigen compared with WT animals (Fig. 5e). Moreover,
vessel-associated T cells were increased in CCR5−/− mice,
while parenchymal T cells predominated in WT animals
(5F). Taken altogether, these data indicate that CCR5 is
not required for antiviral, cell-mediated immunity in the
periphery. In the CNS, however, CCR5 is required for the
entry of leukocytes specifically into cortex.
Discussion
While CCR5 has been shown to be critical for survival
of WNV-infected mice, region-specific roles for this re-
ceptor within the CNS has not been previously de-
scribed. Here, we demonstrate that targeted deletion of
CCR5 leads to loss of virologic control specifically within
cortical tissues of the CNS, which also exhibit enhanced
BBB permeability and elevated levels of CCR5 ligands,
CCL3 and CCL5. Despite these latter findings, WNV-
infected CCR5−/− mice showed decreased infiltration of
all mononuclear cells into cortical regions compared
with similarly infected WT animals. These data suggest
region-specific roles for CCR5 ligands within the virally
infected CNS.
Although mortality of WNV-infected, CCR5−/− mice
were only moderately increased, symptomatic disease was
significantly enhanced. This is reminiscent of findings in
patients with the Δ32CCR5 mutation, which exhibit in-
crease in symptomatic diseases after WNV infection, but
no increase in mortality [22, 34]. In previous studies using
CCR5−/− mice on a B6129PF2 background, infection with
WNV-NY99 led to uniform mortality. The severe pheno-
type observed in CCR5-deficient mice may be due to
strain related variations in inflammatory responses be-
tween C57BL/6 versus mixed background (B6129PF2)
strains [35].
Increased symptoms of encephalitis in CCR5-deficient
mice in our study were associated with increased cortical
viral loads. This region-specific effect is consistent with
the other reports of regional differences in expression of
inflammatory molecules during viral infections of the
Fig. 3 BBB permeability increases within the cortices of the WNV-infected CCR5−/− CNS. a Following inoculation with 102 PFU of WNV in the footpad,
WT and CCR5−/− mice were assessed for BBB sodium fluorescein permeability in different CNS regions on the indicated days post-infection.
BBB permeability was determined by the accumulation of sodium fluorescent dye in CNS tissues after intraperitoneal administration. Data are
shown as mean fluorescence normalized to the mean value for uninfected animals ± SEM for four mice per time point and are representative
of two independent experiments. Asterisks indicate values that are statistically significant (*P < 0.05)
Fig. 4 CCR5 ligands are increased within the cortical region of the CCR5−/− CNS during WNV infection. Expression of chemotactic cytokines was
measured in the (a) cortical and (b) cerebellar regions of the CNS harvested from WNV-infected WT and CCR5−/− mice at day 8 post-infection by
Bio-Plex assay. Results represent means ± SEM of five mice per group. Asterisks indicate values that are statistically significant (***P < 0.001)
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CNS [33, 36]. The lack of effect of CCR5-deficiency on
viral loads in the periphery or in other CNS regions sug-
gests that CCR5+ antiviral lymphocytes are specifically
required for virologic control within the cortex. Of note,
adoptive transfer of CCR5-sufficient cells into WNV-
infected, CCR5-deficient mice were previously shown to
control viral replication and improve survival [21], which
may have been due to improved virologic control in the
forebrain. This is similar to the findings regarding the role
of CXCR3, which is dispensable for the control of viral in-
fection in the periphery and in most CNS compartments
but required for CD8 T cell-mediated antiviral responses
specifically within the cerebellum. That evolutionary older
CXC chemokines would be important for virologic con-
trol in the hindbrain while CC chemokines, which evolved
with adaptive immunity, would play a bigger antiviral role
in the forebrain is quite accordant [19, 37, 38]. Recent
studies also indicate that activated microglia in the setting
of WNV encephalitis express proinflammatory cytokines
and chemokines [39]. Further studies evaluating regional
differences in chemoattractant responses of various neural
cell types during viral infections should yield important in-
sights regarding how viruses differentially impact CNS
antiviral responses.
Fig. 5 CCR5 is necessary for recruitment of mononuclear cells to the cortical region of the WNV-infected CNS. The immunophenotype of brain
leukocytes and their locations within the cortex were determined in WNV-infected WT and CCR5−/− mice. Mice were infected with 102 PFU of
WNV in the footpad. The cerebellum (a, b) and cortex (c, d) were harvested and analyzed by flow cytometry at the indicated days after infection.
In separate infections, cortical tissues from WNV-infected WT and CCR5−/− mice were examined for locations of CD3+ cells with respect to
WNV antigen or the vasculature at day 8 post infection. a, c The numbers of CD45lo and CD45hi leukocyte populations were determined at
the indicated time points after infection. b, d The numbers of CD4+, CD8+, and CD11b+ (macrophage) populations from the CD45hi leukocyte
population were determined at the indicated time points after infection. Results represent the means ± SEM of at least four mice per group.
Asterisks indicate values that are statistically significant (*P < 0.05, **P < 0.01). e Detection of WNV antigen (red) and CD3+ T cells (green). Nuclei
were counterstained (blue). f Detection of CD31+ endothelial cells (red) and CD3+ T cells (green). Images are representative of 10 images per
mouse for 3 mice/genotype. In all images, arrows indicate CD3+ cells. Scale bar = 25 μm
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We previously showed that clearance of virus is associ-
ated with prompt resolution of encephalitis, with decreased
numbers of infiltrating T cells [40]. Consistent with this,
WT mice exhibited increased parenchymal T cells and low
levels of WNV antigen at day 8 post-infection followed by
decreased numbers of CNS-infiltrated leukocytes at day 10
post-infection. CNS infiltrating T cells and macrophages
express cytokines, such as interferon (IFN)-γ, tumor ne-
crosis factor (TNF)-α, and interleukin (IL)-1β, may in-
duce disruption of interendothelial cell tight junctions
(TJs) via activation of the GTPase RhoA [11, 29]. The
resulting increase in BBB permeability is associated
with the migration of mononuclear cells into the CNS
parenchyma, with enhanced viral clearance [40]. In our
study, despite the increase in BBB permeability ob-
served in cortical tissues of WNV-infected, CCR5−/−
mice, significantly fewer leukocytes trafficked into this
CNS region. The increase in BBB permeability in the
setting of high MOIs of WNV is likely due to effects of
inflammasome activation, which disrupts tight junction
integrity via effects of IL-1β [29]. In addition, high
MOIs of WNV which induce necrotic cell death and
cause cells to release immunogenic factors as they die
including inflammatory cytokines like HMGB1, while
low MOIs induce apoptosis, which is typically non-
immunogenic [41]. This is consistent with prior studies
showing that pattern recognition receptor activation in
the presence of WNV in the BBB endothelium results in
cytokine-dependent modulation of Rho GTPase signaling,
exerting regulatory control over BBB permeability and TJ
integrity [29]. Thus, it is possible that the high viral loads
within the cortices of WNV-infected, CCR5−/− mice in-
duce viral sensing mechanisms, such as activation of Toll-
like receptor 3 [29, 42], that promote loss of BBB integrity.
Conclusions
In conclusion, our data identify CCR5 as critically import-
ant for cell-mediated immunity during cortical infections
with neurotropic virus. Loss of CCR5 results in decreased
ability to recruit antiviral mononuclear cells specifically
into WNV-infected, cortical tissues, which are essential
for virologic control. The data also raise new questions re-
garding the effects of high CNS viral loads on BBB perme-
ability and the differential expression of chemokines
within brain regions during viral infections of the CNS.
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